A conspicuous inhibition on MC-C tumor was observed when an anti-CTLA-4 treatment was initiated at early stages of tumor growth; however, as tumor grew, tumor-stimulatory effects were observed (Figure 6B). This evidence concerns the gene CTLA4 and neoplasm.